TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013
TCL Archive Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products. April 22, 2005
TCL Archive Cancer Care Cost To Jump by 27 Percent In a Decade, Reaching $158 Billion in 2020 January 28, 2011
